Stephen Munk has joined the Biodesign Institute at Arizona State University as deputy director of science and technology. In this role, Munk will focus on the strategic, business and technical operations of Arizona’s single largest bioscience research infrastructure investment.
Most recently, Munk was president and CEO of Ash Stevens Inc. in Riverview, Michigan, a pharmaceutical development and manufacturing company, where he became known for his success in gaining rapid FDA approval for novel therapies.
“With our aging population and growing threats to our air, energy and water, we need to find new ways to hasten the complicated and time-intensive process that brings new discoveries from the research lab to the world,” said Joshua LaBaer, executive director of the Biodesign Institute.
“ASU has earned its reputation as the top university in the nation when it comes to innovation,” said LaBaer. “Now is the perfect time to engage someone with Stephen’s reputation for taking innovation into the marketplace where it can have its greatest impact.”